# Hormonal Factors in the Treatment of Anorexia Nervosa

> **NCT01121211** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 90 (actual)

## Conditions studied

- Anorexia Nervosa
- Eating Disorder
- Anxiety
- Depression

## Interventions

- **DRUG:** Testosterone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01121211
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2020-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01121211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01121211, "Hormonal Factors in the Treatment of Anorexia Nervosa". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT01121211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*